Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
about
Cancer stem cells (CSCs), cervical CSCs and targeted therapiesOxygen-induced cell migration and on-line monitoring biomarkers modulation of cervical cancers on a microfluidic system.Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathwayDiscovery of fruquintinib, a potent and highly selective small molecule inhibitor of VEGFR 1, 2, 3 tyrosine kinases for cancer therapy.Radiation-induced miR-208a increases the proliferation and radioresistance by targeting p21 in human lung cancer cellsA dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells.Role of osteopontin in the pathophysiology of cancer.Osteopontin as a therapeutic target for cancer.Update on implications and mechanisms of angiogenesis in liver fibrosis.Immunolocalization of osteopontin in dysplasias and squamous cell carcinomas arising from oral epithelium.Osteopontin -- a promising biomarker for cancer therapy.Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer.Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis.Osteopontin: its potential role in cancer of children and young adults.Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation.Clinical Significance of Circulating Osteopontin Levels in Patients With Lung Cancer and Correlation With VEGF and MMP-9.MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1α) in the tumor microenvironmentsContrast-Enhanced Ultrasonography Features of Breast Malignancies with Different Sizes: Correlation with Prognostic FactorsDownregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α.Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.Clinical and in vitro analysis of Osteopontin as a prognostic indicator and unveil its potential downstream targets in bladder cancer.Tumor Acidosis and Hypoxia Differently Modulate the Inflammatory Program: Measurements In Vitro and In Vivo.Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.Delisheng induces antiproliferation and apoptosis effects in Hep3B cells via modulation of angiogenic proteins.Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer.HIF-2α-ILK Is Involved in Mesenchymal Stromal Cell Angiogenesis in Multiple Myeloma Under Hypoxic Conditions.The role of osteopontin in the progression of solid organ tumour.Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor.Co(II)-mediated effects of plain and plasma immersion ion implanted cobalt-chromium alloys on the osteogenic differentiation of human mesenchymal stem cells.
P2860
Q26747144-8EAD46FF-2F32-46F8-BD9A-3A79C70D711CQ30844742-A67EE458-1DA4-43EB-B40C-D17B49EE0C9BQ33766277-42DE47F3-B612-419F-A732-0A844B626862Q35740040-C58EAF47-612E-4921-AF6C-7DC64C8472B8Q36212825-EC583850-9F43-4119-98E9-C4D6D18F703AQ36454693-37AEF5EA-A571-41BE-AF33-5D0AC26C5D27Q37379468-A4CAFF3C-C9E5-4A8C-94BD-EEC5EF3C2E32Q37615918-E24FC2A8-4359-48DF-8053-BC02FA123E34Q37641586-77EB7C0E-75C3-45D0-8303-4DD8C0DEC2A0Q38198463-17A93D80-5D97-4053-978E-D42B9A0E6B44Q38217758-CF8D4F33-4DEA-4EDE-B342-1E3C4F195DC5Q38246718-F6975B2B-CA7B-4F4B-BC5A-F7B368DBCA6CQ38374593-60406A9B-DCE5-4926-865C-FB0C88B83846Q38619009-8ECC7ED6-3262-496E-AF85-0346FE9A60E7Q38724150-78ACF08E-32B0-4D0D-8923-0008EAC62656Q39004667-B65839DB-D763-47AC-8446-60942F676E66Q39192350-5EA8BF0A-473E-47B4-9B45-33C6229D8EF6Q39428665-2DC74270-16DA-42F1-B7E3-2D2502678CF3Q40582898-B486BF4E-5BE9-4AA4-97EE-B3532A20AE98Q41947730-7DC83B19-EC4B-4C31-9C91-0946FD1004F1Q42257587-8ADF28E4-52E9-496E-BF9C-C49719EE3212Q45324940-96C891DF-1EB6-477F-B7D2-EA527E6CD45BQ46915042-A6433844-0D4B-4F20-834A-86DDA7559429Q47131436-CEB1AD24-5222-488A-9DE2-B86D855913CDQ47132574-0F54592B-3FAC-4EAE-9267-863750ED777BQ47196315-57377CAF-0FE0-4F58-AB6C-17F51665DC2FQ47357582-DBCFEE74-D413-4C2E-85B6-A79A10F47C83Q47375825-B6BFF9D3-BAD9-48A7-91EE-B00699B49110Q47426563-340E41FC-7326-481A-80B3-8B8731814FAAQ52321084-A5EABC92-AE30-465C-9E6B-247410B835CEQ52676361-C4253E21-C31A-4A47-94F6-D5B156F0D5E5Q53078264-FF6A7D10-51D4-4E80-87DB-F4F73F24297BQ53672250-96279576-2918-47E8-BAE9-9A6CA8451FCA
P2860
Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@en
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@nl
type
label
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@en
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@nl
prefLabel
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@en
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@nl
P2093
P2860
P356
P1433
P1476
Hypoxia-driven osteopontin con ...... d VEGF-dependent angiogenesis.
@en
P2093
G Soundararajan
P2860
P2888
P304
P356
10.1038/ONC.2013.171
P407
P50
P577
2013-06-03T00:00:00Z